[Importance of neoadjuvant chemotherapy in gastrointestinal tumors. A new standard?]

Med Klin (Munich). 2007 Jul 15;102(7):551-62; quiz 563-4. doi: 10.1007/s00063-007-1069-5.

[Article in German]

Authors

Nicolas Moosmann¹, Stefan Boeck, Volker Heinemann

Affiliation

¹ Medizinische Klinik III , Universitätsklinikum München-Grosshadern, Marchioninistrasse 15, 81377 München. Nicolas.Moosmann@med.uni-muenchen.de

PMID: 17634873
DOI: 10.1007/s00063-007-1069-5

No abstract available

Publication types

Case Reports

MeSH terms

Adenocarcinoma / drug therapy
Adenocarcinoma / pathology
Adenocarcinoma / radiotherapy
Adenocarcinoma / surgery
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Combined Modality Therapy
Gastrointestinal Neoplasms / drug therapy*
Gastrointestinal Neoplasms / pathology
Gastrointestinal Neoplasms / radiotherapy
Gastrointestinal Neoplasms / surgery
Humans
Lymphatic Metastasis / pathology
Male
Middle Aged
Neoadjuvant Therapy*
Neoplasm Staging
Radiotherapy, Adjuvant
Rectal Neoplasms / drug therapy
Rectal Neoplasms / pathology
Rectal Neoplasms / radiotherapy
Rectal Neoplasms / surgery
Survival Rate